Article

Neuralink has successfully implanted its innovative brain chips in twelve patients globally, allowing individuals with severe paralysis to control devices with their thoughts. This milestone signifies a significant advancement in medical technology, following initial safety concerns raised by the FDA.

The implants, developed in collaboration with the Barrow Neurological Institute, have been in use for over 2,000 days, demonstrating their reliability and potential applications. As the technology progresses, it may reshape the medical landscape, setting Neuralink apart in a competitive field.